Join Now

Author Archives: admin

Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

By admin | Published October 9, 2020

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY, October 5, 2020–– Xenocor, Inc. offering the world’s first disposable articulating laparoscope, has received a group purchasing agreement with Premier Inc. for their single use Xenoscope™, in the surgical disposable scope category. The Xenocor disposable laparoscopic system […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

By admin | Published October 9, 2020

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October 5, 2020 – Mountain Pacific Venture Fund (MPVF) announced an investment in Xenocor, a Salt Lake City, Utah-based medical device company that has developed the Xenoscope™, a single-use, multi-purpose HD laparoscope with an integrated light source. Designed […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

2020 Bench to Bedside Participants Announced

By admin | Published September 18, 2020

Courtesy of University of Utah Academics & Research Postponed from its original in-person event last April, the annual medical innovation challenge has moved entirely online this year. Tuesday September 8, 2020 | Salt Lake City, UT Nearly five months after postponing the original in-person event in response to COVID-19, the 10th Annual Bench to Bedside competition […]

Posted in Industry News | Leave a comment

Clene Nanomedicine, Inc. Completes Enrollment in Rescue-ALS Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8

By admin | Published September 11, 2020

Clene Nanomedicine, Inc., (“Clene”) a clinical-stage biopharmaceutical company and its Australian subsidiary, Clene Australia Pty Ltd., on Tuesday announced the completion of patient enrollment in its RESCUE-ALS Phase 2 study. The multi-center study is designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of CNM-Au8 in early symptomatic ALS patients. The objective of this study […]

Posted in BioUtah News, Life Sciences Industry News | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

By admin | Published September 11, 2020

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | Leave a comment

Utah Leads Together Accountability Framework

By admin | Published September 11, 2020

This Utah Leads Together Accountability Framework presents Utah’s strategic, data-driven, and concentrated effort to protect the lives and livelihoods of all Utahns. The framework includes a clear mission, two major goals, six supporting objectives, and a variety of lead measures and strategies. A scorecard of measurable targets motivates progress. Together with a refined accountability structure, […]

Posted in COVID-19 Updates | Leave a comment

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

By admin | Published September 11, 2020

By Chris Gibson, PhD via Recursion – Drug discovery partnership and equity investment led by Leaps by Bayer in Series D financing round – Digitally-powered drug discovery to address fibrotic diseases with previously undiscovered mechanisms and to deliver novel therapies to patients faster Berlin, Germany and Salt Lake City, USA, September 9, 2020 – Bayer and […]

Posted in Industry News, Life Sciences Industry News | Leave a comment

HHS Move Upends FDA Role in Laboratory-Developed Test Regulation

By admin | Published August 28, 2020

By Adam Bonislawski for GenomeWeb NEW YORK – In a surprise move, the US Department of Health and Human Services said on Wednesday that it had determined the Food and Drug Administration would not require premarket review of laboratory-developed tests without notice-and-comment rulemaking. The announcement, which took many in the lab industry aback, appeared to […]

Posted in COVID-19 Updates, HHS/FDA & Other Regulatory | Leave a comment

Clene Nanomedicine Raises Series D Financing of $42.5 Million

By admin | Published August 28, 2020

SALT LAKE CITY, August 26, 2020 – Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced that it has secured $42.5 million in a Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment vehicle. Participants in the round included existing investors, as well as new institutional investors from South Korea […]

Posted in Policy News | Leave a comment

BioUtah and Utah Biotech/Biopharma Companies Raise Concerns About Impact of Trump’s “Most-Favored-Nation” Drug Pricing Order on Innovation

By admin | Published August 19, 2020

BioUtah, along with 10 Utah biotech and biopharma companies, have sent letters to Utah’s U.S. Senators and Representatives urging opposition to the President’s directive to impose “most-favored nation” pricing on Medicare Part B drugs. The letter notes that if the executive order moves forward, investment dollars for Utah’s smaller drug discovery companies could dry up […]

Posted in Industry News, Policy News | Leave a comment

2020 IPO Comeback Webcast Series from PwC

By admin | Published August 13, 2020

After IPO issuances came to a near-halt in late Q1 and early Q2, the window reopened wide this summer, when much-needed liquidity infused the markets and led to one of the strongest months for IPOs in 13 years. Join us for a two-part executive webcast series on the novel challenges of capital raising during a […]

Posted in Events | Leave a comment

COVID-19 Grant Relief Program Updates as of 8/12/2020 9:20 am

By admin | Published August 13, 2020

Shop In Utah: $35M (+ $10M added from ComRent) Opened Monday, July 27 – closed August 7, 2020, at 1:30 p.m. Shop in Utah number of applications received: 872 Shop in Utah total award amount requested: $42,344,434 Shop in Utah number of awards: 653 Shop in Utah total award amount: $26,790,444 Average award amount: $41,023 […]

Posted in Funding | Leave a comment

A Special Thanks To Our Elite Members